Get the Stockscreener App
14.19
2.68%
0.37
After Hours:
14.16
-0.025
-0.18%
Range Cancer Therapeutics Etf stock is traded at $14.19, with a volume of 3,341.
It is up +2.68% in the last 24 hours and down -3.44% over the past month.
See More
Previous Close:
$13.81
Open:
$13.92
24h Volume:
3,341
Relative Volume:
0.92
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+5.70%
1M Performance:
-3.44%
6M Performance:
-2.91%
1Y Performance:
+33.95%
1-Day Range:
$13.92
$14.19
1-Week Range:
$13.09
$14.19
52-Week Range:
$10.51
$17.96
Range Cancer Therapeutics Etf Stock (CNCR) Company Profile
Name
Range Cancer Therapeutics Etf
Sector
Industry
Phone
-
Address
-
Compare CNCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNCR
Range Cancer Therapeutics Etf
|
14.19 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
298.20 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
598.83 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
601.82 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
259.72 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
505.30 | 124.43B | 0 | 0 | 0 | 0.00 |
Range Cancer Therapeutics Etf Stock (CNCR) Latest News
Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge Funds - MSN
Daniel Dunaief - TBR News Media
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
CSHL and Range ETFs launch new partnership - Cold Spring Harbor Laboratory
(CNCR) Long Term Investment Analysis - Stock Traders Daily
Trackinsight ETF data from 11th to 15th November, 2024 - ETF Express
The Best Biotech Stocks to Buy - Morningstar
Charted: Cancer Survival Rates Over Time - Visual Capitalist
Range Cancer Therapeutics - TBR News Media
How this award-winning TV host is setting the stage to help protect her health - TBR News Media
Investment fund pledges revenues in cancer research partnership with CSHL - TBR News Media
(CNCR) Trading Signals - Stock Traders Daily
At a Glance: Nov. 6 - Crain's New York Business
7 Best-Performing Biotech ETFs for November 2024 - NerdWallet
(CNCR) Trading Report - Stock Traders Daily
The 5 Best Biotech ETFs of 2024 - TradingView
Microsoft Corp (MSFT-Q) QuotePress Release - The Globe and Mail
Science & Technology - TBR News Media
(CNCR) Investment Report - Stock Traders Daily
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
4 Cancer Stocks to Consider in 2024 - The Motley Fool
The Zacks Analyst Blog SFYX, CNCR, FXN and DIV - Yahoo Finance
4 Solid ETFs Under $20 for Your Portfolio - Yahoo Finance
(CNCR) Investment Analysis - Stock Traders Daily
Summit Therapeutics: Cancer Drug With Great Potential On 'Fast Track' To US Market (SMMT) - Seeking Alpha
Trackinsight ETF data from 23rd to 27th September, 2024 - ETF Express
(CNCR) Investment Analysis and Advice - Stock Traders Daily
When the Price of (CNCR) Talks, People Listen - Stock Traders Daily
Breaking Down Acrivon: Deep Dive Into Revenue, Profitability, And Prospects (NASDAQ:ACRV) - Seeking Alpha
7 Top Gene-Editing Stocks to Buy | Investing - U.S News & World Report Money
Roundhill Investments Surpasses $2 Billion AUM Milestone – Company Announcement - Financial Times
5 ETFs That Led the Rebound on Monday - Yahoo Finance
IPO Roundup: Bicara Therapeutics, Kairos Pharma and more (NYSEARCA:IPO) - Seeking Alpha
Trading (CNCR) With Integrated Risk Controls - Stock Traders Daily
Cellectis: Cheap With Promising But Speculative Cancer Therapies (NASDAQ:CLLS) - Seeking Alpha
Best-Performing ETF Areas of Past Week - MSN
TScan Therapeutics: Speculative Buy With Near-Term Catalysts In Oncology (TCRX) - Seeking Alpha
Why It May Be 'Just Right' to Invest in Cancer Therapeutics Development Stocks Now - Nasdaq
3 Top-Ranked ETFs Under $20 for Your Portfolio - MSN
Invest in Hope, Invest in Life - Nasdaq
5 Top-Ranked ETFs to Buy at a Bargain - Yahoo Finance
Wall Street indexes rise after strong jobs data - Yahoo News Canada
VIXY Jumped 7.3% Last Week - Yahoo Finance
SPY Led Inflows Last Week as Leveraged Funds Surged - etf.com
Best ETFs of Last Week - Yahoo Finance
US stocks waver, extending tech-led selloff - Yahoo Singapore News
Time for Healthcare ETFs? - Yahoo Finance
TSLA-related ETFs among top performing ETFs on a 4-week performance base last week - MSN
5 Top ETFs of Last Week - Yahoo Finance
Range Cancer Therapeutics Etf Stock (CNCR) Financials Data
There is no financial data for Range Cancer Therapeutics Etf (CNCR). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.04%
0.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):